The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells.
Open accessAbstract
The biological response to progesterone is mediated by two distinct forms of the human progesterone receptor (hPR-A and hPR-B). In most cell contexts, hPR-B functions as a transcriptional activator of progesterone-responsive genes, whereas hPR-A functions as a transcriptional inhibitor of all steroid hormone receptors. We have created mutations within the carboxyl terminus of hPR which differentially effect the transcriptional activity of hPR-B in a cell- and promoter-specific manner. Analogous mutations, when introduced into hPR-A, have no effect on its ability to inhibit the transcriptional activity of other steroid hormone receptors. The observed differences in the structural requirements for hPR-B and hPR-A function suggest that transcriptional activation and repression by PR are mediated by two separate pathways within the cell. In support of this hypothesis, we have shown that hPR-A mediated repression of human estrogen receptor (hER) transcriptional activity is not dependent on hER expression level but depends largely on the absolute expression level of hPR-A. Thus, it appears that hPR-A inhibits hER transcriptional activity as a consequence of a noncompetitive interaction of hPR-A with either distinct cellular targets or different contact sites on the same target. We propose that hPR-A expression facilitates a ligand-dependent cross-talk among sex steroid receptor signaling pathways within the cell. It is likely, therefore, that alterations in the expression level of hPR-A or its cellular target can have profound effects on the physiological or pharmacological responses to sex steroid hormone receptor ligands.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yung-Chi, C., & Prusoff, W. H. (1973) · Biochemical Pharmacology · doi:10.1016/0006-2952(73)90196-2 · Cited by 12,922
Kastner, P., Krust, A., Turcotte, B., Stropp, U., Tora, L., Gronemeyer, H., & Chambon, P. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08280.x · Cited by 1,534
A graphic method for the determination and presentation of binding parameters in a complex system
Rosenthal, H. E. (1967) · Analytical Biochemistry · doi:10.1016/0003-2697(67)90297-7 · Cited by 1,512
Transcriptional activation: A complex puzzle with few easy pieces
Tjian, R., & Maniatis, T. (1994) · Cell · doi:10.1016/0092-8674(94)90227-5 · Cited by 1,099
Danielian, P. S., White, R., Lees, J. A., & Parker, M. G. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05141.x · Cited by 803
Vegeto, E., Shahbaz, M. M., Wen, D. X., Goldman, M. E., O'Malley, B. W., & McDonnell, D. P. (1993) · Molecular Endocrinology · doi:10.1210/mend.7.10.8264658 · Cited by 760
Self-citationTzukerman, M. T. (1994) · Molecular Endocrinology · doi:10.1210/me.8.1.21 · Cited by 671
Progestin regulation of cellular proliferation.
CLARKE, C. L., & SUTHERLAND, R. L. (1990) · Endocrine Reviews · doi:10.1210/edrv-11-2-266 · Cited by 650 · cited 3×
“Both progesterone and estrogen are involved in the maintenance and development of female reproductive function and additionally are involved in the progression of hormone-dependent breast tumors (8).”
BackgroundInfluentialHoey, T., Weinzierl, R. O. J., Gill, G., Chen, J.-L., Dynlacht, B. D., & Tjian, R. (1993) · Cell · doi:10.1016/0092-8674(93)90664-c · Cited by 572
Contragestion and Other Clinical Applications of RU 486, an Antiprogesterone at the Receptor
Baulieu, E.-E. (1989) · Science · doi:10.1126/science.2781282 · Cited by 483
Berger, S. L., Piña, B., Silverman, N., Marcus, G. A., Agapite, J., Regier, J. L., Triezenberg, S. J., & Guarente, L. (1992) · Cell · doi:10.1016/0092-8674(92)90100-q · Cited by 435
The N-terminal region of the chicken progesterone receptor specifies target gene activation
Tora, L., Gronemeyer, H., Turcotte, B., Gaub, M.-P., & Chambon, P. (1988) · Nature · doi:10.1038/333185a0 · Cited by 421
Members of the steroid hormone receptor superfamily interact with TFIIB (S300-II).
Ing, N. H., Beekman, J. M., Tsai, S. Y., Tsai, M. J., & O'Malley, B. W. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)37087-5 · Cited by 336
Agonistic and antagonistic activities of RU486 on the functions of the human progesterone receptor.
Meyer, M. E., Pornon, A., Ji, J. W., Bocquel, M. T., Chambon, P., & Gronemeyer, H. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07613.x · Cited by 328
Tung, L., Mohamed, M. K., Hoeffler, J. P., Takimoto, G. S., & Horwitz, K. B. (1993) · Molecular Endocrinology · doi:10.1210/mend.7.10.8123133 · Cited by 324
Bocquel, M. T., Kumar, V., Stricker, C., Chambon, P., & Gronemeyer, H. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.7.2581 · Cited by 292
Higuchi, R. (1989) · PCR Technology · doi:10.1007/978-1-349-20235-5_6 · Cited by 291
More is better: Activators and repressors from the same gene
Foulkes, N. S., & Sassone-Corsi, P. (1992) · Cell · doi:10.1016/0092-8674(92)90178-f · Cited by 268
Jiang, S.-Y., & Jordan, V. C. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.8.580 · Cited by 261
HORWITZ, K. B., & ALEXANDER, P. S. (1983) · Endocrinology · doi:10.1210/endo-113-6-2195 · Cited by 232
Danielian, P. S. (1993) · Molecular Endocrinology · doi:10.1210/me.7.2.232 · Cited by 223
Klein-Hitpass, L., Tsai, S. Y., Weigel, N. L., Allan, G. F., Riley, D., Rodriguez, R., Schrader, W. T., Tsai, M.-L., & O'Malley, B. W. (1990) · Cell · doi:10.1016/0092-8674(90)90740-6 · Cited by 212
McDonnell, D. P., & Goldman, M. E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32664-9 · Cited by 211
Self-citationBrandon, D. D., Bethea, C. L., Strawn, E. Y., Novy, M. J., Burry, K. A., Harrington, M. S., Erickson, T. E., Warner, C., Keenan, E. J., & Clinton, G. M. (1993) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(93)90135-6 · Cited by 207
Meyer, M. E., Quirin-Stricker, C., Lerouge, T., Bocquel, M. T., & Gronemeyer, H. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50100-4 · Cited by 169
Kettel, L. M., Murphy, A. A., Mortola, J. F., Liu, J. H., Ulmann, A., & Yen, S. S. C. (1991) · Fertility and Sterility · doi:10.1016/s0015-0282(16)54531-2 · Cited by 151
McDonnell, D. P., Shahbaz, M. M., Vegeto, E., & Goldman, M. E. (1994) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(94)90190-2 · Cited by 151
Self-citationGottardis, M. M., Robinson, S. P., & Jordan, V. C. (1988) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(88)90113-6 · Cited by 147
LESSEY, B. A., SUE ALEXANDER, P., & HORWITZ, K. B. (1983) · Endocrinology · doi:10.1210/endo-112-4-1267 · Cited by 141
Zajchowski, D. A., Sager, R., & Webster, L. (1993) · PubMed · Cited by 113
The antiprogestin RU486 in advanced breast cancer: preliminary clinical trial.
Romieu, G., Maudelondé, T., Ulmann, A., Pujol, H., Grenier, J., Cavalie, G., Khalaf, S., & Rochefort, H. (1987) · PubMed · Cited by 98
Interaction of glucocorticoid analogues with the human glucocorticoid receptor
Berger, T. S., Parandoosh, Z., Perry, B. W., & Stein, R. B. (1992) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(92)90414-e · Cited by 76
Progestin-Mediated Changes in Progesterone Receptor Forms in the Normal Human Endometrium*
Feil, P. D., Clarke, C. L., & SATYASWAROOP, P. G. (1988) · Endocrinology · doi:10.1210/endo-123-5-2506 · Cited by 57
The antiprogestin RU486 in advanced breast cancer: Preliminary clinical trial
Romieu, G., Maudelondé, T., & Ulmann, A. (1988) · Maturitas · doi:10.1016/0378-5122(88)90165-x · Cited by 35
Cited by
Physiological Action of Progesterone in Target Tissues*
Graham, J. D., & Clarke, C. L. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.4.0308 · Cited by 1,008
McKay, L. I., & Cidlowski, J. A. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.4.0375 · Cited by 805
Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform
Mulac-Jericevic, B., Mullinax, R. A., DeMayo, F. J., Lydon, J. P., & Conneely, O. M. (2000) · Science · doi:10.1126/science.289.5485.1751 · Cited by 704
Connections and Regulation of the Human Estrogen Receptor
McDonnell, D. P., & Norris, J. D. (2002) · Science · doi:10.1126/science.1071884 · Cited by 579
Self-citationProgesterone Receptor Isoform A But Not B Is Expressed in Endometriosis1
Attia, G. R., Zeitoun, K., Edwards, D., Johns, A., Carr, B. R., & Bulun, S. E. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.8.6739 · Cited by 193
Metadata
- Authors
- Wen, D. X., Xu, Y. F., Mais, D. E., Goldman, M. E., & McDonnell, D. P.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 1994-12
- Volume
- 14
- Issue
- 12
- Pages
- 8356-8364
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2124295934
- Cited by
- 355
- References
- 34
- FWCI
- 6.13
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.